Latest Insider Transactions at Gilead Sciences, Inc. (GILD)
This section provides a real-time view of insider transactions for Gilead Sciences, Inc. (GILD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GILEAD SCIENCES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GILEAD SCIENCES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2023
|
Sandra Patterson SVP, Controllership |
BUY
Exercise of conversion of derivative security
|
Direct |
298
+0.4%
|
-
|
|
Dec 10
2023
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,247
-1.35%
|
$98,513
$79.02 P/Share
|
|
Dec 10
2023
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,730
+2.88%
|
-
|
|
Dec 10
2023
|
Merdad Parsey Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,269
-1.74%
|
$100,251
$79.02 P/Share
|
|
Dec 10
2023
|
Merdad Parsey Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,779
+3.67%
|
-
|
|
Dec 10
2023
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,341
-0.85%
|
$263,939
$79.02 P/Share
|
|
Dec 10
2023
|
Daniel Patrick O'Day Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,347
+1.84%
|
-
|
|
Dec 10
2023
|
Sandra Patterson SVP, Controllership |
SELL
Payment of exercise price or tax liability
|
Direct |
222
-0.72%
|
$17,538
$79.02 P/Share
|
|
Dec 10
2023
|
Sandra Patterson SVP, Controllership |
BUY
Exercise of conversion of derivative security
|
Direct |
518
+1.66%
|
-
|
|
Dec 10
2023
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,194
-1.11%
|
$94,326
$79.02 P/Share
|
|
Dec 10
2023
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,617
+2.37%
|
-
|
|
Nov 10
2023
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
804
-0.76%
|
$60,300
$75.92 P/Share
|
|
Nov 10
2023
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,912
+1.77%
|
-
|
|
Oct 25
2023
|
Deborah H Telman EVP, Corporate Affairs & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
243
-3.47%
|
$18,954
$78.39 P/Share
|
|
Oct 25
2023
|
Deborah H Telman EVP, Corporate Affairs & GC |
BUY
Exercise of conversion of derivative security
|
Direct |
514
+6.84%
|
-
|
|
Oct 17
2023
|
Andrew D Dickinson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.59%
|
$400,000
$80.0 P/Share
|
|
Sep 12
2023
|
Merdad Parsey Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,501
-2.1%
|
$114,076
$76.99 P/Share
|
|
Sep 10
2023
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,203
-1.09%
|
$91,428
$76.0 P/Share
|
|
Sep 10
2023
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,619
+2.32%
|
-
|
|
Sep 10
2023
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,256
-1.38%
|
$95,456
$76.0 P/Share
|
|
Sep 10
2023
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,730
+2.92%
|
-
|
|
Sep 10
2023
|
Sandra Patterson SVP, Controllership |
SELL
Payment of exercise price or tax liability
|
Direct |
149
-0.49%
|
$11,324
$76.0 P/Share
|
|
Sep 10
2023
|
Sandra Patterson SVP, Controllership |
BUY
Exercise of conversion of derivative security
|
Direct |
519
+1.69%
|
-
|
|
Sep 10
2023
|
Merdad Parsey Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,278
-1.75%
|
$97,128
$76.0 P/Share
|
|
Sep 10
2023
|
Merdad Parsey Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,779
+3.67%
|
-
|
|
Sep 10
2023
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,366
-0.87%
|
$255,816
$76.0 P/Share
|
|
Sep 10
2023
|
Daniel Patrick O'Day Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,348
+1.86%
|
-
|
|
Aug 10
2023
|
Sandra Patterson SVP, Controllership |
SELL
Payment of exercise price or tax liability
|
Direct |
1,306
-4.2%
|
$104,480
$80.0 P/Share
|
|
Aug 10
2023
|
Sandra Patterson SVP, Controllership |
BUY
Exercise of conversion of derivative security
|
Direct |
4,484
+12.62%
|
-
|
|
Jul 25
2023
|
Deborah H Telman EVP, Corporate Affairs & GC |
BUY
Exercise of conversion of derivative security
|
Direct |
10,289
+36.48%
|
-
|
|
Jul 25
2023
|
Deborah H Telman EVP, Corporate Affairs & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
4,174
-48.5%
|
$321,398
$77.23 P/Share
|
|
Jul 24
2023
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,174
-6.16%
|
$244,398
$77.66 P/Share
|
|
Jul 24
2023
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,505
+12.72%
|
-
|
|
Jul 20
2023
|
Andrew D Dickinson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.44%
|
$400,000
$80.0 P/Share
|
|
Jun 13
2023
|
Merdad Parsey Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,485
-4.81%
|
$112,860
$76.9 P/Share
|
|
Jun 10
2023
|
Sandra Patterson SVP, Controllership |
SELL
Payment of exercise price or tax liability
|
Direct |
153
-0.57%
|
$11,934
$78.12 P/Share
|
|
Jun 10
2023
|
Sandra Patterson SVP, Controllership |
BUY
Exercise of conversion of derivative security
|
Direct |
517
+1.9%
|
-
|
|
Jun 10
2023
|
Merdad Parsey Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,294
-4.02%
|
$100,932
$78.12 P/Share
|
|
Jun 10
2023
|
Merdad Parsey Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,779
+7.95%
|
-
|
|
Jun 10
2023
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,272
-2.81%
|
$99,216
$78.12 P/Share
|
|
Jun 10
2023
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,730
+5.69%
|
-
|
|
Jun 10
2023
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,409
-1.26%
|
$265,902
$78.12 P/Share
|
|
Jun 10
2023
|
Daniel Patrick O'Day Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,346
+2.65%
|
-
|
|
Jun 10
2023
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,219
-1.63%
|
$95,082
$78.12 P/Share
|
|
Jun 10
2023
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,618
+3.38%
|
-
|
|
May 03
2023
|
Jacqueline K Barton Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,887
+7.82%
|
-
|
|
May 03
2023
|
Sandra Horning Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,887
+34.2%
|
-
|
|
May 03
2023
|
Kevin E Lofton Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,887
+2.0%
|
-
|
|
May 03
2023
|
Harish Manwani Director |
SELL
Payment of exercise price or tax liability
|
Direct |
368
-3.23%
|
$29,072
$79.45 P/Share
|
|
May 03
2023
|
Harish Manwani Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,887
+14.22%
|
-
|